HREC Approval of the Initiation of Phase 1 Study of GXV-001 in Australia
2022/6/10
GEXVal Inc.June 10, 2022 GEXVal Inc. has invited experienced doctors and specialists from Japan, Australia, Sw […]
Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regular Meeting
2022/2/24
GEXVal Inc.February 24, 2022 Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regul […]
Presentation in New Year’s Social Event of Independence Club
2022/1/12
GEXVal Inc.January 12, 2022 CEO of GEXVal Inc., Dr. Juran Kato, presented at the New Year’s Social Event of th […]